دورية أكاديمية
أعرض في EDS

NF-κB inhibitor alpha controls SARS-CoV-2 infection in ACE2-overexpressing human airway organoids.

التفاصيل البيبلوغرافية
العنوان: NF-κB inhibitor alpha controls SARS-CoV-2 infection in ACE2-overexpressing human airway organoids.
المؤلفون: Simoneau CR; Gladstone Institute of Virology, San Francisco, CA, USA.; Biomedical Sciences Graduate Program, University of California San Francisco, San Francisco, CA, USA., Chen PY; Gladstone Institute of Virology, San Francisco, CA, USA., Xing GK; Chan-Zuckerberg Biohub, San Francisco, CA, USA.; Center for Computational Biology, University of California, Berkeley, Berkeley, CA, USA., Hayashi JM; Gladstone Institute of Virology, San Francisco, CA, USA., Chen IP; Gladstone Institute of Virology, San Francisco, CA, USA.; Biomedical Sciences Graduate Program, University of California San Francisco, San Francisco, CA, USA., Khalid MM; Gladstone Institute of Virology, San Francisco, CA, USA., Meyers NL; Gladstone Institute of Virology, San Francisco, CA, USA., Taha TY; Gladstone Institute of Virology, San Francisco, CA, USA., Leon KE; Gladstone Institute of Virology, San Francisco, CA, USA.; Medical Scientist Training Program, University of California San Francisco, San Francisco, CA, USA., Suryawanshi RK; Gladstone Institute of Virology, San Francisco, CA, USA., McCavitt-Malvido M; Gladstone Institute of Virology, San Francisco, CA, USA., Ashuach T; Center for Computational Biology, University of California, Berkeley, Berkeley, CA, USA., Fontaine KA; Gladstone Institute of Virology, San Francisco, CA, USA., Rodriguez L; ImmunoX CoLabs, University of California San Francisco, San Francisco, CA, USA., Joehnk B; Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA., Walcott K; Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA., Vasudevan S; Medical Service, San Francisco VA Healthcare System, San Francisco, CA, USA., Fang X; Department of Medicine and Department of Anesthesia, Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, USA., Maishan M; Department of Medicine and Department of Anesthesia, Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, USA., Schultz S; Center for Computational Biology, University of California, Berkeley, Berkeley, CA, USA., Roose JP; Department of Anatomy, University of California San Francisco, San Francisco, CA, USA., Matthay MA; Department of Medicine and Department of Anesthesia, Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, USA., Sil A; Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA., Arjomandi M; Medical Service, San Francisco VA Healthcare System, San Francisco, CA, USA.; Division of Pulmonary and Critical Care, Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Yosef N; Center for Computational Biology, University of California, Berkeley, Berkeley, CA, USA. nir.yosef@weizmann.ac.il.; Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel. nir.yosef@weizmann.ac.il., Ott M; Gladstone Institute of Virology, San Francisco, CA, USA. melanie.ott@gladstone.ucsf.edu.; Chan-Zuckerberg Biohub, San Francisco, CA, USA. melanie.ott@gladstone.ucsf.edu.; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA. melanie.ott@gladstone.ucsf.edu.
المصدر: Scientific reports [Sci Rep] 2024 Jul 04; Vol. 14 (1), pp. 15351. Date of Electronic Publication: 2024 Jul 04.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
أسماء مطبوعة: Original Publication: London : Nature Publishing Group, copyright 2011-
مواضيع طبية MeSH: Organoids*/virology , Organoids*/metabolism , Angiotensin-Converting Enzyme 2*/metabolism , Angiotensin-Converting Enzyme 2*/genetics , SARS-CoV-2*/physiology , COVID-19*/virology , COVID-19*/metabolism , COVID-19*/genetics , Virus Replication* , NF-KappaB Inhibitor alpha*/metabolism , NF-KappaB Inhibitor alpha*/genetics, Humans ; NF-kappa B/metabolism
مستخلص: As SARS-CoV-2 continues to spread worldwide, tractable primary airway cell models that recapitulate the cell-intrinsic response to arising viral variants are needed. Here we describe an adult stem cell-derived human airway organoid model overexpressing the ACE2 receptor (ACE2-OE) that supports robust viral replication while maintaining 3D architecture and cellular diversity of the airway epithelium. ACE2-OE organoids were infected with SARS-CoV-2 variants and subjected to single-cell RNA-sequencing. Interferon-lambda was upregulated in cells with low-level infection while the NF-kB inhibitor alpha gene (encoding IkBa) was consistently upregulated in infected cells, and its expression positively correlated with infection levels. Confocal microscopy showed more IkBa expression in infected than bystander cells, but found concurrent nuclear translocation of NF-kB that IkBa usually prevents. Overexpressing a nondegradable IkBa mutant reduced NF-kB translocation and increased viral infection. These data demonstrate the functionality of ACE2-OE organoids in SARS-CoV-2 research and underscore that the strength of the NF-kB feedback loop in infected cells controls viral replication.
(© 2024. The Author(s).)
التعليقات: Update of: bioRxiv. 2022 Aug 02:2022.08.02.502100. doi: 10.1101/2022.08.02.502100. (PMID: 35982664)
References: Dis Model Mech. 2021 Jun 1;14(6):. (PMID: 34219165)
Sci Transl Med. 2021 Apr 21;13(590):. (PMID: 33723017)
Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2122236119. (PMID: 35858406)
Am J Physiol Lung Cell Mol Physiol. 2022 Sep 1;323(3):L372-L389. (PMID: 35762590)
Cell. 2020 Jul 23;182(2):429-446.e14. (PMID: 32526206)
Front Cell Infect Microbiol. 2022 Mar 14;12:841447. (PMID: 35360113)
J Virol. 2021 Nov 9;95(23):e0125721. (PMID: 34523966)
Nat Commun. 2023 Oct 6;14(1):6245. (PMID: 37803001)
Cell Host Microbe. 2020 Jun 10;27(6):870-878. (PMID: 32464097)
Cell Stem Cell. 2020 Dec 3;27(6):859-868. (PMID: 33275899)
Nat Commun. 2021 Jul 16;12(1):4354. (PMID: 34272374)
Nature. 2021 Jan;589(7841):270-275. (PMID: 33116299)
Science. 2020 Jul 3;369(6499):50-54. (PMID: 32358202)
Mol Syst Biol. 2021 Jan;17(1):e9620. (PMID: 33491336)
J Virol. 2006 May;80(10):5059-64. (PMID: 16641297)
Nature. 2020 Nov;587(7835):619-625. (PMID: 33208946)
Stem Cell Reports. 2023 Mar 14;18(3):636-653. (PMID: 36827975)
Nat Biotechnol. 2022 Feb;40(2):163-166. (PMID: 35132262)
Cell. 2021 Jun 24;184(13):3426-3437.e8. (PMID: 33991487)
Mol Cell Biol. 1996 Mar;16(3):1058-65. (PMID: 8622650)
Cell. 2021 Jan 7;184(1):106-119.e14. (PMID: 33333024)
Nat Commun. 2021 Sep 21;12(1):5556. (PMID: 34548483)
Front Cell Dev Biol. 2020 Nov 05;8:574706. (PMID: 33224945)
Nat Protoc. 2016 Sep;11(9):1724-43. (PMID: 27560176)
Emerg Microbes Infect. 2023 Dec;12(2):2276338. (PMID: 37883246)
Nat Commun. 2020 Nov 18;11(1):5885. (PMID: 33208793)
Genome Biol. 2014;15(12):550. (PMID: 25516281)
EMBO J. 2019 Feb 15;38(4):. (PMID: 30643021)
Mod Pathol. 2020 Nov;33(11):2156-2168. (PMID: 32879413)
Nature. 2022 Mar;603(7902):706-714. (PMID: 35104837)
Genome Biol. 2018 Feb 6;19(1):15. (PMID: 29409532)
Nat Biotechnol. 2019 Jun;37(6):685-691. (PMID: 31061482)
Emerg Microbes Infect. 2022 Dec;11(1):926-937. (PMID: 35259078)
Elife. 2021 Aug 13;10:. (PMID: 34463615)
Nat Methods. 2018 Dec;15(12):1053-1058. (PMID: 30504886)
Virology. 2020 Sep;548:39-48. (PMID: 32838945)
J Virol. 1999 May;73(5):4502-7. (PMID: 10196356)
Proc Natl Acad Sci U S A. 2018 Jun 26;115(26):6822-6827. (PMID: 29891677)
Bioinformatics. 2013 Jan 1;29(1):15-21. (PMID: 23104886)
Signal Transduct Target Ther. 2020 Sep 21;5(1):209. (PMID: 32958760)
Semin Immunol. 2014 Jun;26(3):253-66. (PMID: 24958609)
Cell. 2019 Jun 13;177(7):1888-1902.e21. (PMID: 31178118)
Curr Opin Virol. 2018 Apr;29:79-86. (PMID: 29656244)
Bioinformatics. 2020 Feb 1;36(3):964-965. (PMID: 31400197)
Nat Commun. 2019 Apr 3;10(1):1523. (PMID: 30944313)
Nat Rev Immunol. 2020 May;20(5):279-293. (PMID: 31853049)
Nature. 2020 Dec;588(7839):670-675. (PMID: 33238290)
Mucosal Immunol. 2021 Sep;14(5):978-990. (PMID: 33608655)
Cell Stem Cell. 2020 Dec 3;27(6):876-889.e12. (PMID: 33232663)
Proc Natl Acad Sci U S A. 2022 Apr 19;119(16):e2119680119. (PMID: 35353667)
معلومات مُعتمدة: W81XWH-20-1-0158 Departments of Defense; 2U19AI135990 NIH/NIAID; CXV-00125 Veterans Affairs; T29IR0715 California Tobacco-related Disease Research Program; P01-AI091580 NIH/NIAID; P01 AI091580 United States AI NIAID NIH HHS; 28FT-0020 California Tobacco-related Disease Research Program; 3P01AI091580-09S1 United States GF NIH HHS; U19 AI135990 United States AI NIAID NIH HHS
المشرفين على المادة: EC 3.4.17.23 (Angiotensin-Converting Enzyme 2)
EC 3.4.17.23 (ACE2 protein, human)
139874-52-5 (NF-KappaB Inhibitor alpha)
0 (NF-kappa B)
SCR Organism: SARS-CoV-2 variants
تواريخ الأحداث: Date Created: 20240703 Date Completed: 20240703 Latest Revision: 20240715
رمز التحديث: 20240715
مُعرف محوري في PubMed: PMC11222426
DOI: 10.1038/s41598-024-66003-2
PMID: 38961189
قاعدة البيانات: MEDLINE
الوصف
تدمد:2045-2322
DOI:10.1038/s41598-024-66003-2